A Phase 2, Non-Randomized, Controlled, Open-Label, Parallel-Group, Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-pregnant Subjects.
Phase of Trial: Phase II
Latest Information Update: 06 Jan 2017
At a glance
- Drugs Streptococcal B vaccine conjugate (Primary)
- Indications Streptococcal infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors GlaxoSmithKline
- 10 Dec 2016 Status changed from active, no longer recruiting to completed.
- 14 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 20 Apr 2016 Status changed from not yet recruiting to recruiting.